Literature DB >> 12145103

A desensitization-selective potentiator of AMPA-type glutamate receptors.

Masayuki Sekiguchi1, Kaori Nishikawa, Shunsuke Aoki, Keiji Wada.   

Abstract

1: We examined the effects of PEPA, an allosteric potentiator of AMPA receptors, on AMPA receptor kinetics. 2: PEPA did not affect the deactivation of glutamate responses but potently attenuated the extent of receptor desensitization without slowing the onset of desensitization in most of the recombinant AMPA receptors (GluR1-flip, GluR1-flop, GluR3-flip, GluR3-flip+GluR2-flip, and GluR3-flop+GluR2-flop) expressed in Xenopus oocytes. For the GluR3-flop subunit, PEPA attenuated the extent of desensitization and only weakly prolonged deactivation (1.3 fold). 3: PEPA did not significantly affect recovery from desensitization in oocytes expressing GluR3-flip, GluR1-flop, and GluR1-flop, but weakly accelerated (2.6 fold) recovery from desensitization in oocytes expressing GluR3-flop. 4: PEPA's effect on desensitization of GluR3-flop-containing receptors is unique in that onset is very slow. 5: Simulation studies using simplified kinetic models for AMPA receptors are utilized to explore the differential effects of PEPA on GluR3-flip and -flop. It is possible to simulate the action on GluR3-flip by modulating two rate constants in a 12-state kinetic model. For simulation of the action on GluR3-flop, the 12-state kinetic model is not enough, and it is necessary to invoke a 13th state, a PEPA-bound receptor to which glutamate cannot bind. 6: These results suggest that attenuation of extent of desensitization represents the principal mechanism underlying the potentiation of AMPA receptors by PEPA, and that PEPA exhibits different mechanisms with respect to GluR3-flip and GluR3-flop.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145103      PMCID: PMC1573432          DOI: 10.1038/sj.bjp.0704804

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Structural determinants of ion flow through recombinant glutamate receptor channels.

Authors:  T A Verdoorn; N Burnashev; H Monyer; P H Seeburg; B Sakmann
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

2.  AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.

Authors:  K M Partin; M W Fleck; M L Mayer
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

3.  The mechanism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor desensitization after removal of glutamate.

Authors:  I M Raman; L O Trussell
Journal:  Biophys J       Date:  1995-01       Impact factor: 4.033

4.  Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.

Authors:  A Arai; M Kessler; G Rogers; G Lynch
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

5.  Currents through single glutamate receptor channels in outside-out patches from rat cerebellar granule cells.

Authors:  J R Howe; S G Cull-Candy; D Colquhoun
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

6.  The AMPA receptor allosteric potentiator PEPA ameliorates post-ischemic memory impairment.

Authors:  M Sekiguchi; K Yamada; J Jin; M Hachitanda; Y Murata; S Namura; S Kamichi; I Kimura; K Wada
Journal:  Neuroreport       Date:  2001-09-17       Impact factor: 1.837

7.  Facilitation of glutamate receptors enhances memory.

Authors:  U Staubli; G Rogers; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.

Authors:  D M Thompson; A Guidotti; M DiBella; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.

Authors:  K M Partin; D K Patneau; M L Mayer
Journal:  Mol Pharmacol       Date:  1994-07       Impact factor: 4.436

10.  Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.

Authors:  R Cumin; E F Bandle; E Gamzu; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more
  15 in total

1.  Mechanisms underlying signal filtering at a multisynapse contact.

Authors:  Timotheus Budisantoso; Ko Matsui; Naomi Kamasawa; Yugo Fukazawa; Ryuichi Shigemoto
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

Review 2.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins.

Authors:  Akihiko S Kato; Martin B Gill; Michelle T Ho; Hong Yu; Yuan Tu; Edward R Siuda; He Wang; Yue-Wei Qian; Eric S Nisenbaum; Susumu Tomita; David S Bredt
Journal:  Neuron       Date:  2010-12-22       Impact factor: 17.173

Review 4.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

Review 5.  Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders.

Authors:  Stefano Marenco; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Physiological significance of high- and low-affinity agonist binding to neuronal and recombinant AMPA receptors.

Authors:  Markus Kessler; Erika Suzuki; Kyle Montgomery; Amy C Arai
Journal:  Neurochem Int       Date:  2008-03-08       Impact factor: 3.921

7.  Stargazin controls the pharmacology of AMPA receptor potentiators.

Authors:  Susumu Tomita; Masayuki Sekiguchi; Keiji Wada; Roger A Nicoll; David S Bredt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

8.  Ligand-binding domain determines endoplasmic reticulum exit of AMPA receptors.

Authors:  Sarah K Coleman; Tommi Möykkynen; Sami Hinkkuri; Lauri Vaahtera; Esa R Korpi; Olli T Pentikäinen; Kari Keinänen
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

9.  Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.

Authors:  Ahmed H Ahmed; Christopher P Ptak; Robert E Oswald
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

10.  Modulation of agonist binding to AMPA receptors by 1-(1,4-benzodioxan-6-ylcarbonyl)piperidine (CX546): differential effects across brain regions and GluA1-4/transmembrane AMPA receptor regulatory protein combinations.

Authors:  Kyle E Montgomery; Markus Kessler; Amy C Arai
Journal:  J Pharmacol Exp Ther       Date:  2009-08-28       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.